BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17926152)

  • 1. Prospective observational multi-poison center study of ziprasidone exposures.
    Klein-Schwartz W; Lofton AL; Benson BE; Spiller HA; Crouch BI
    Clin Toxicol (Phila); 2007; 45(7):782-6. PubMed ID: 17926152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of ziprasidone exposures reported to Texas poison centers, 2001-2005.
    Forrester MB
    Hum Exp Toxicol; 2008 Apr; 27(4):355-61. PubMed ID: 18684807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ziprasidone overdose: cases recorded in the database of Pfizer-Spain and literature review.
    Gómez-Criado MS; Bernardo M; Florez Td; Gutiérrez JR; Gandía R; Ayani I
    Pharmacotherapy; 2005 Nov; 25(11):1660-5. PubMed ID: 16232029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.
    Kelly DL; Love RC
    Psychopharmacol Bull; 2001; 35(4):66-79. PubMed ID: 12397857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric ziprasidone overdose.
    Fasano CJ; O'Malley GF; Lares C; Rowden AK
    Pediatr Emerg Care; 2009 Apr; 25(4):258-9. PubMed ID: 19369840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case series of ziprasidone overdoses.
    Bryant SM; Zilberstein J; Cumpston KL; Magdziarz DD; Costerisan DD
    Vet Hum Toxicol; 2003 Mar; 45(2):81-2. PubMed ID: 12678292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Cobaugh DJ; Erdman AR; Booze LL; Scharman EJ; Christianson G; Manoguerra AS; Caravati EM; Chyka PA; Woolf AD; Nelson LS; Troutman WG
    Clin Toxicol (Phila); 2007 Dec; 45(8):918-42. PubMed ID: 18163235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsade de pointes after ziprasidone overdose with coingestants.
    Alipour A; Cruz R; Lott RS
    J Clin Psychopharmacol; 2010 Feb; 30(1):76-7. PubMed ID: 20075653
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute quetiapine overdose in adults: a 5-year retrospective case series.
    Ngo A; Ciranni M; Olson KR
    Ann Emerg Med; 2008 Nov; 52(5):541-7. PubMed ID: 18433934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital Holter measurement of QT prolongation in ziprasidone overdose.
    Berling I; Isbister GK; Calver L; Clunas S
    Clin Toxicol (Phila); 2011 Aug; 49(7):694-6. PubMed ID: 21819290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential relationship between QTc interval prolongation and ziprasidone treatment: three cases.
    Eker SS; Sarandol A; Akkaya C; Sivrioglu EY; Kirli S
    J Psychopharmacol; 2009 Nov; 23(8):993-6. PubMed ID: 18635710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
    Minov C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S142-4. PubMed ID: 15570533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].
    Finzel M; Fric M; Laux G
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S178-80. PubMed ID: 15570546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unintentional ingestion of ziprasidone in a 22-month-old.
    MacVane CZ; Baumann MR
    Pediatr Emerg Care; 2009 Jul; 25(7):460-2. PubMed ID: 19606003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study.
    Blair J; Scahill L; State M; Martin A
    J Am Acad Child Adolesc Psychiatry; 2005 Jan; 44(1):73-9. PubMed ID: 15608546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.
    Biswas AK; Zabrocki LA; Mayes KL; Morris-Kukoski CL
    J Toxicol Clin Toxicol; 2003; 41(1):79-82. PubMed ID: 12645973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
    Cutler AJ; Kalali AH; Weiden PJ; Hamilton J; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S20-8. PubMed ID: 18334909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.
    Biswas AK; Zabrocki LA; Mayes KL; Morris-Kukoski CL
    J Toxicol Clin Toxicol; 2003; 41(2):101-4. PubMed ID: 12733844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective review of California poison control system data of sibutramine exposures.
    Minns AB; Ebrahimi S; Te L; Ly B; Clark RF; Cantrell FL
    Clin Toxicol (Phila); 2009 Sep; 47(8):814-7. PubMed ID: 19778191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose ziprasidone associated with QT interval prolongation.
    Witsil JC; Zell-Kanter M; Mycyk MB
    Am J Emerg Med; 2012 Jun; 30(5):837.e1-2. PubMed ID: 21641143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.